Search

Home
Staff
Sarah Al Ashmori Theophile Bigirumurame Andy Bryant Thomas Chadwick Svetlana Cherlin Mike Cole Holly Fisher Tony Fouweather Shaun Hiu Dorcas Kareithi Ann Breeze Konkoth Nan Lin Jingky Lozano-Kuehne Helen Mossop Ellen Moss Jérémie Nsengimana Vicky Ryan Marzieh Shahmandi Moha Shojaei Dawn Teare James Wason Faye Williamson Nina Wilson Sylvia Zhang
PhD students
Ruqayya Azher Nicole Cizauskas Laura Etfer Niamh Fitzgerald Raiann Hamshaw Aritra Mukherjee Pela Okorie Samuel Sarkodie Lou Whitehead
Methodology research
Overview Adaptive designs Master protocols Transforming IMID trials
Projects
Publications
News
Courses
Adaptive Designs and Multiple Testing Procedures Leveraging External Information Precision Medicine Clinical Trials
Contact

Curtin NJ

PARP1 expression, activity and ex vivo sensitivity to the PARP inhibitor, talazoparib (BMN 673), in chronic lymphocytic leukaemia
Poly(ADP-ribose) polymerase-1 (PARP-1) pharmacogenetics, activity and expression analysis in cancer patients and healthy volunteers
Doxorubicin-induced suppression of poly(ADP-ribose) polymerase-1 (PARP-1) activity and expression and its implication for PARP inhibitors in clinical trials
Poly(ADP-ribose) polymerase-1 polymorphisms, expression and activity in selected human tumour cell lines

Published with Wowchemy — the free, open source website builder that empowers creators.